Kaye Flitney, from the UK is one of 75 people enrolled in the clinical trial


DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.